1. Cholesterol lowering and the reduction of CHD incidence and total mortality: Results from a meta-analysis of randomized trials

   • Ingar Holme

   Editorial Comment on the Value of Lowering Blood Cholesterol Pages: 101 - 102

2. Cholesterol biosynthesis and metabolism

   • David W. Russell

   Editorial Comment on the Value of Lowering Blood Cholesterol Pages: 103 - 110

3. Advances in thrombolytic therapy

   • M. Verstraete

   State-of-the-Art Lecture Pages: 111 - 124

4. Can we really justify the treatment of silent ischemia in 1992? No!

   • David Mulcahy
   • Kim Fox

   State-of-the-Art Lecture Pages: 125 - 129

5. Cholesterol and coronary disease —Outstanding questions

   • Michael F. Oliver

   State-of-the-Art Lecture Pages: 131 - 136

6. Do calcium entry blockers act on circulating ionized calcium?

   • Konstantine A. Merzon
   • Victoria V. Kolomiets

   Letter to the Editor Pages: 137 - 137

7. Syncope and recurrent long sinus arrest in vasospastic angina

   • Junichi Hasegawa
   • Hideyuki Kitamura
   • Hiroto Mashiba

   Letter to the Editor Pages: 139 - 139

8. Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: Randomized controlled trial versus hydrochlorothiazide

   • Rosario Scaglione
   • Angelo Indovina
   • Giuseppe Licata

   Hypertension Pages: 141 - 146

9. Regression of left ventricular hypertrophy in “Previously untreated” hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy

   • Elyse Foster
   • Jonathan F. Plehn
   • Carl S. Apstein

   Hypertension Pages: 147 - 151

10. Low-dose verapamil in middle-aged and elderly patients with angina pectoris: No evidence of increased susceptibility to the cardiac effects

    • Jawad H. Ahmed
    • Henry L. Elliott
    • John L. Reid

    Angina Pectoris Pages: 153 - 158

11. HN-10200 causes endothelium-independent relaxations in isolated canine arteries

    • Francesco Cosentino
    • Alexander Schirger
    • Zvonimir S. Katušić

    Experimental Pharmacology Pages: 159 - 165

12. Reduction of exercise-induced regional contractile dysfunction in dogs using a novel calcium channel blocker (Ro 40-5967)

    • Brian D. Guth

    Experimental Pharmacology Pages: 167 - 171

13. Comparison of captopril with enalapril in the treatment of heart failure: Influence on hemodynamics and measures of renal function

    • Karl Josef Osterziel
    • Rainer Dietz
    • Wolfgang Kübler

    Experimental Pharmacology Pages: 173 - 180

14. Choice of ACE inhibitor for congestive heart failure

    Experimental Pharmacology Pages: 181 - 181

15. Long-term hemodynamic effects of nifedipine on congenital heart disease with eisenmenger's mechanism in children

    • Maria Wimmer
    • Michael Schlemmer

    Congenital Heart Disease Pages: 183 - 186

16. Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: Comparison of two regimens

    • Béatrice Brembilla-Perrot
    • Etienne Aliot
    • Jacques Victor

    Ventricular Tachycardia Pages: 187 - 193